EMR/ESD中黏膜下注射材料的研究进展  

Research Progress of Submucosal Injection Solutions for EMR/ESD

作　　者：吕历[1] 高燕[1] 

机构地区：[1]广东医学院附属南山医院消化内科,广东深圳518052

出　　处：《医学综述》2011年第22期3476-3478,共3页Medical Recapitulate

摘　　要：内镜下黏膜切除术(EMR)及内镜黏膜下剥离术(ESD)逐渐成为一种切除消化道癌前病变与早癌的一种标准微创治疗手段。使用黏膜下注射让黏膜隆起便于切除,有效的黏膜下注射可以减少EMR/ESD的并发症。随着癌前病变与早癌检出率的升高,用于EMR/ESD的技术也在不段完善和提高。现从EMR/ESD的发展对一些新型的黏膜下注射材料进行归纳与阐述,以便寻找理想的黏膜下注射材料。Endoscopic mucosal resection（EMR）and endoscopic submucosal dissection（ESD）have gradually become standard minimally invasive treatments for resection of gastrointestinal precancerous lesions and early carcinomas.EMR/ESD techniques require the use of submucosal injection,which lifts the mucosa to be resected,and reduces complications of EMR/ESD.Here is to summarize novel submucosal injection solutions through the advancement in the field of EMR/ESD due to the requirements aroused from the increased precancerous and early carcinoma detection rate,to seek the ideal solution for submucosal injection.

关 键 词：内镜下黏膜切除术 内镜黏膜下剥离术 黏膜下注射 保护性黏膜下水垫 透明质酸 

分 类 号：R735[医药卫生—肿瘤]